| Name | Title | Contact Details |
|---|
We are a proudly Canadian healthcare company, providing diversified healthcare services across the country.
BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Creative Community Living is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winfield, KS. To find more information about Creative Community Living, please visit www.cclccl.org
SCA`s vision is to be the partner of choice for physicians, hospitals, and health systems in developing and operating ambulatory surgery centers and surgical hospitals across the country and in enhancing hospital-based surgical departments. SCA owns and/or provides management services to 210 ambulatory surgery centers, surgical hospitals, and hospital surgery departments, in partnership with approximately 7,500 physicians and in affiliation with 110 health systems. SCA`s clinical systems, service line growth strategies, benchmarking processes, and efficiency programs create measurable advantage for surgical facilities ā clinically, operationally, and financially.
The RNSĀ® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.